[Solitary bone plasmocytoma: treatment and outcome features].
Identifieur interne : 000068 ( PubMed/Corpus ); précédent : 000067; suivant : 000069[Solitary bone plasmocytoma: treatment and outcome features].
Auteurs : L. Kochbati ; N Kédidi Ben Romdhane ; K. Mrad ; C. Nasr ; D E Ben Salah ; K. Ben Romdhane ; M. MaalejSource :
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [ 1278-3218 ] ; 2004.
English descriptors
- KwdEn :
- Adult, Biopsy, Bone Neoplasms (drug therapy), Bone Neoplasms (pathology), Bone Neoplasms (radiotherapy), Bone Neoplasms (surgery), Cobalt Radioisotopes (therapeutic use), Combined Modality Therapy, Female, Follow-Up Studies, Humans, Laminectomy, Male, Middle Aged, Multiple Myeloma (etiology), Plasmacytoma (drug therapy), Plasmacytoma (pathology), Plasmacytoma (radiotherapy), Plasmacytoma (surgery), Radioisotope Teletherapy, Radiotherapy, High-Energy, Retrospective Studies, Spinal Neoplasms (drug therapy), Spinal Neoplasms (pathology), Spinal Neoplasms (radiotherapy), Spinal Neoplasms (surgery), Tibia (pathology), Time Factors, Treatment Outcome.
- MESH :
- chemical , therapeutic use : Cobalt Radioisotopes.
- drug therapy : Bone Neoplasms, Plasmacytoma, Spinal Neoplasms.
- etiology : Multiple Myeloma.
- pathology : Bone Neoplasms, Plasmacytoma, Spinal Neoplasms, Tibia.
- radiotherapy : Bone Neoplasms, Plasmacytoma, Spinal Neoplasms.
- surgery : Bone Neoplasms, Plasmacytoma, Spinal Neoplasms.
- Adult, Biopsy, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Laminectomy, Male, Middle Aged, Radioisotope Teletherapy, Radiotherapy, High-Energy, Retrospective Studies, Time Factors, Treatment Outcome.
Abstract
- To describe natural history of solitary bone plasmocytomas (SBO) after treatment.
DOI: 10.1016/j.canrad.2003.11.003
PubMed: 15063873
Links to Exploration step
pubmed:15063873Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Solitary bone plasmocytoma: treatment and outcome features].</title><author><name sortKey="Kochbati, L" sort="Kochbati, L" uniqKey="Kochbati L" first="L" last="Kochbati">L. Kochbati</name><affiliation><nlm:affiliation>Service de radiothérapie carcinologique, institut Salah-Azaïz, Bab-Saadoun, 1006 Tunis, Tunisie. lofti.kochbati@rns.tn</nlm:affiliation></affiliation></author><author><name sortKey="Ben Romdhane, N Kedidi" sort="Ben Romdhane, N Kedidi" uniqKey="Ben Romdhane N" first="N Kédidi" last="Ben Romdhane">N Kédidi Ben Romdhane</name></author><author><name sortKey="Mrad, K" sort="Mrad, K" uniqKey="Mrad K" first="K" last="Mrad">K. Mrad</name></author><author><name sortKey="Nasr, C" sort="Nasr, C" uniqKey="Nasr C" first="C" last="Nasr">C. Nasr</name></author><author><name sortKey="Ben Salah, D E" sort="Ben Salah, D E" uniqKey="Ben Salah D" first="D E" last="Ben Salah">D E Ben Salah</name></author><author><name sortKey="Ben Romdhane, K" sort="Ben Romdhane, K" uniqKey="Ben Romdhane K" first="K" last="Ben Romdhane">K. Ben Romdhane</name></author><author><name sortKey="Maalej, M" sort="Maalej, M" uniqKey="Maalej M" first="M" last="Maalej">M. Maalej</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15063873</idno><idno type="pmid">15063873</idno><idno type="doi">10.1016/j.canrad.2003.11.003</idno><idno type="wicri:Area/PubMed/Corpus">000068</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000068</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Solitary bone plasmocytoma: treatment and outcome features].</title><author><name sortKey="Kochbati, L" sort="Kochbati, L" uniqKey="Kochbati L" first="L" last="Kochbati">L. Kochbati</name><affiliation><nlm:affiliation>Service de radiothérapie carcinologique, institut Salah-Azaïz, Bab-Saadoun, 1006 Tunis, Tunisie. lofti.kochbati@rns.tn</nlm:affiliation></affiliation></author><author><name sortKey="Ben Romdhane, N Kedidi" sort="Ben Romdhane, N Kedidi" uniqKey="Ben Romdhane N" first="N Kédidi" last="Ben Romdhane">N Kédidi Ben Romdhane</name></author><author><name sortKey="Mrad, K" sort="Mrad, K" uniqKey="Mrad K" first="K" last="Mrad">K. Mrad</name></author><author><name sortKey="Nasr, C" sort="Nasr, C" uniqKey="Nasr C" first="C" last="Nasr">C. Nasr</name></author><author><name sortKey="Ben Salah, D E" sort="Ben Salah, D E" uniqKey="Ben Salah D" first="D E" last="Ben Salah">D E Ben Salah</name></author><author><name sortKey="Ben Romdhane, K" sort="Ben Romdhane, K" uniqKey="Ben Romdhane K" first="K" last="Ben Romdhane">K. Ben Romdhane</name></author><author><name sortKey="Maalej, M" sort="Maalej, M" uniqKey="Maalej M" first="M" last="Maalej">M. Maalej</name></author></analytic><series><title level="j">Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</title><idno type="ISSN">1278-3218</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Biopsy</term><term>Bone Neoplasms (drug therapy)</term><term>Bone Neoplasms (pathology)</term><term>Bone Neoplasms (radiotherapy)</term><term>Bone Neoplasms (surgery)</term><term>Cobalt Radioisotopes (therapeutic use)</term><term>Combined Modality Therapy</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Laminectomy</term><term>Male</term><term>Middle Aged</term><term>Multiple Myeloma (etiology)</term><term>Plasmacytoma (drug therapy)</term><term>Plasmacytoma (pathology)</term><term>Plasmacytoma (radiotherapy)</term><term>Plasmacytoma (surgery)</term><term>Radioisotope Teletherapy</term><term>Radiotherapy, High-Energy</term><term>Retrospective Studies</term><term>Spinal Neoplasms (drug therapy)</term><term>Spinal Neoplasms (pathology)</term><term>Spinal Neoplasms (radiotherapy)</term><term>Spinal Neoplasms (surgery)</term><term>Tibia (pathology)</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Cobalt Radioisotopes</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Bone Neoplasms</term><term>Plasmacytoma</term><term>Spinal Neoplasms</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Multiple Myeloma</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Bone Neoplasms</term><term>Plasmacytoma</term><term>Spinal Neoplasms</term><term>Tibia</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Bone Neoplasms</term><term>Plasmacytoma</term><term>Spinal Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Bone Neoplasms</term><term>Plasmacytoma</term><term>Spinal Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Biopsy</term><term>Combined Modality Therapy</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Laminectomy</term><term>Male</term><term>Middle Aged</term><term>Radioisotope Teletherapy</term><term>Radiotherapy, High-Energy</term><term>Retrospective Studies</term><term>Time Factors</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">- To describe natural history of solitary bone plasmocytomas (SBO) after treatment.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15063873</PMID><DateCreated><Year>2004</Year><Month>4</Month><Day>5</Day></DateCreated><DateCompleted><Year>2004</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1278-3218</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>2</Issue><PubDate><Year>2004</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</Title><ISOAbbreviation>Cancer Radiother</ISOAbbreviation></Journal><ArticleTitle>[Solitary bone plasmocytoma: treatment and outcome features].</ArticleTitle><Pagination><MedlinePgn>70-4</MedlinePgn></Pagination><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">- To describe natural history of solitary bone plasmocytomas (SBO) after treatment.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">- Between 1975 and 1998, we retrospectively identified 13 patients with SBO treated in the department of radiotherapy at Salah-Azaïz institute of Tunis. To be included in this study, three criteria were needed: histologic confirmation and only one bone lesion without medullary infiltration (or less than 10%). Mean age was 43 years (22-64) with sex-ratio of 3,3. Tumor sites were vertebra (6), flat bones (6) and tibia (1). Megavoltage radiotherapy was given to all patients, associated to surgery in eight cases (5 excisions and 3 laminectomies) and to chemotherapy in three.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">- With a mean follow-up of 63 months, two local failures were noted at 24 and 48 months. Two patients developed multifocal lesions and one patient had an extramedullary lesion. Multiple myeloma occurred in four patients (30%) after a median follow-up 3,5 years. Unfavorable outcome could not be predicted by age, gender or site of disease but by myeloma protein.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">- Radiotherapy is an effective local treatment for solitary bone plasmocytoma. Prospective studies are needed to better define predictive parameters of unfavourable outcome and indications of combined chemotherapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kochbati</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Service de radiothérapie carcinologique, institut Salah-Azaïz, Bab-Saadoun, 1006 Tunis, Tunisie. lofti.kochbati@rns.tn</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Romdhane</LastName><ForeName>N Kédidi</ForeName><Initials>NK</Initials></Author><Author ValidYN="Y"><LastName>Mrad</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Nasr</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Ben Salah</LastName><ForeName>D E</ForeName><Initials>DE</Initials></Author><Author ValidYN="Y"><LastName>Ben Romdhane</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Maalej</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>ENG</Language><Language>FRE</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Cancer Radiother</MedlineTA><NlmUniqueID>9711272</NlmUniqueID><ISSNLinking>1278-3218</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003037">Cobalt Radioisotopes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001859" MajorTopicYN="N">Bone Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003037" MajorTopicYN="N">Cobalt Radioisotopes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007796" MajorTopicYN="N">Laminectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009101" MajorTopicYN="N">Multiple Myeloma</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010954" MajorTopicYN="N">Plasmacytoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011867" MajorTopicYN="N">Radioisotope Teletherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011882" MajorTopicYN="N">Radiotherapy, High-Energy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013125" MajorTopicYN="N">Spinal Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013977" MajorTopicYN="N">Tibia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>May</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2003</Year><Month>Oct</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>Nov</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>4</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>5</Month><Day>21</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>4</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15063873</ArticleId><ArticleId IdType="doi">10.1016/j.canrad.2003.11.003</ArticleId><ArticleId IdType="pii">S1278321803001380</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000068 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000068 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= CobaltMaghrebV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:15063873
|texte= [Solitary bone plasmocytoma: treatment and outcome features].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:15063873" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CobaltMaghrebV1
| This area was generated with Dilib version V0.6.32. |  |